Biotechnology Research Center, Hubei Province Key Laboratory of Natural Products Research and Development, China Three Gorges University, Yichang, People's Republic of China.
J Mater Sci Mater Med. 2010 Jan;21(1):309-17. doi: 10.1007/s10856-009-3827-9. Epub 2009 Jul 26.
Deficient vascularization is one of the prominent shortcomings of porous tissue-engineering scaffolds, which results in insufficient oxygen and nutrients transportation. Here, heparin cross-linked demineralized bone matrices (HC-DBM) pre-loaded with vascular endothelial growth factor (VEGF) were designed to promote cells and new microvessels invasion into the matrices. After being chemical crosslinked with heparin by N-hydroxysuccinimide and N-(3-di-methylaminopropyl)-N'-ethylcarbodiimide, the scaffold could bind more VEGF than the non-crosslinked one and achieve localized and sustained delivery. The biological activity of VEGF binding on heparinized collagen was demonstrated by promoting endothelial cells proliferation. Evaluation of the angiogenic potential of heparinized DBM loaded with VEGF was further investigated by subcutaneous implantation. Improved angiogenesis of heparinized DBM loaded with VEGF was observed from haematoxylin-eosin staining and immunohistochemistry examination. The results demonstrated that heparin cross-linked DBM binding VEGF could be a useful strategy to stimulate cells and blood vessels invasion into the scaffolds.
血管生成不足是多孔组织工程支架的突出缺点之一,这导致了氧气和营养物质输送的不足。在这里,设计了肝素交联脱钙骨基质(HC-DBM),以负载血管内皮生长因子(VEGF),以促进细胞和新微血管侵入基质。通过 N-羟基琥珀酰亚胺和 N-(3-二甲基氨基丙基)-N'-乙基碳二亚胺与肝素进行化学交联后,支架比非交联支架能够结合更多的 VEGF,并实现局部和持续的释放。通过促进内皮细胞增殖,证明了 VEGF 结合肝素化胶原的生物学活性。通过皮下植入进一步研究了负载 VEGF 的肝素化 DBM 的血管生成潜力。从苏木精-伊红染色和免疫组织化学检查中观察到肝素化 DBM 负载 VEGF 的血管生成得到改善。结果表明,肝素交联 DBM 结合 VEGF 可能是刺激细胞和血管侵入支架的有效策略。